Two Sigma Advisers
ENZN

Two Sigma Advisers’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Two Sigma Advisers’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-14,700
Closed -$7K – 2298
2016
Q1 		$7K Hold
14,700
– – ﹤0.01% 2016
2015
Q4 		$10K Sell
14,700
-5,600
-28% -$4.44K ﹤0.01% 1848
2015
Q3 		$20K Buy
+20,300
New +$25K ﹤0.01% 1777
2015
Q1 		– Sell
-165,119
Closed -$180K – 2617
2014
Q4 		$180K Sell
165,119
-17,000
-9% -$17.8K ﹤0.01% 2239
2014
Q3 		$197K Buy
182,119
+27,100
+17% +$33.5K ﹤0.01% 2139
2014
Q2 		$161K Sell
155,019
-5,300
-3% -$5.05K ﹤0.01% 2309
2014
Q1 		$165K Buy
160,319
+40,023
+33% +$41.3K ﹤0.01% 2129
2013
Q4 		$140K Buy
120,296
+14,477
+14% +$22.3K ﹤0.01% 2183
2013
Q3 		$178K Sell
105,819
-6,800
-6% -$12.6K ﹤0.01% 1947
2013
Q2 		$225K Buy
+112,619
New +$330K ﹤0.01% 1900

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $409M AUM 17.6% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Two Sigma Advisers's ENZN Position: Q2 2016 in Review

Two Sigma Advisers sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 14,700 shares — an estimated $7K sold.

Two Sigma Advisers first reported a position in ENZN in Q2 2013 and held it in 10 quarters. The position peaked at $225K in Q2 2013. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • Two Sigma Advisers reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • Two Sigma Advisers sold 14,700 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $7K.
  • Two Sigma Advisers first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 10 quarters.
  • Two Sigma Advisers's ENZON PHARMACEUTICALS INC position peaked at $225K in Q2 2013.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Two Sigma Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.